Skip to main content
. 2020 Mar 11;20:96. doi: 10.1186/s12886-020-01360-w

Table 3.

The incidence rate and incidence risk ratio of dry eye syndrome in the systemic lupus erythematosus cohort and comparison cohort (N = 5393)

Disorder (ICD-9-CM) SLE cohort (n = 450) comparison cohort (n = 4943) IRR (95% CI) Adjusted IRRa (95% CI)
No. of patient Person-years IR No. of patient Person-years IR P P
Dry eye syndrome (375.15, 710.2, 370.33) Overall 107 2577 41.52 298 32,189 9.26 4.48 (3.60–5.59) <  0.001 4.45 (3.54–5.58) <  0.001
Sex
 male 9 259 34.75 29 3472 8.35 4.16 (1.97–8.78) <  0.001 4.46 (2.08–9.58) <  0.001
 female 98 2318 42.28 269 28,717 9.37 4.51 (3.58–5.69) <  0.001 4.45 (3.50–5.65) < 0.001
Age group (years)
 20–39 50 1564 31.97 126 18,357 6.86 4.66 (3.37–6.46) < 0.001 4.43 (3.16–6.21) < 0.001
 40–59 43 787 54.64 117 10,618 11.02 4.96 (3.50–7.03) < 0.001 4.89 (3.41–7.01) < 0.001
  > 60 14 226 61.95 55 3214 17.11 3.62 (2.01–6.51) < 0.001 3.50 (1.94–6.34) < 0.001

CI Confidence interval, ICD-9-CM International Classification of Diseases, Ninth revision, clinical modification, IR Incidence rate per 1000 person-years, IRR Incidence rate ratio, n.c. Not calculable, SLE Systemic lupus erythematosus

aAdjusted for age, sex, socioeconomic status, and geographic region